课题基金 / 基金详情

Lung Development in Congenital Diaphragmatic Hernia

Lung Development in Congenital Diaphragmatic Hernia
先天性膈疝的肺部发育
批准号:
6759449
负责人:
JANET E LARSON
金额:
$6.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2005-06-30

项目摘要

项目成果

JANET E LARSON的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):先天性膈疝(CDH)与肺发育不全的结构异常有关。这些变化在硝芬诱导的CDH啮齿动物模型中被模拟。硝基芬(2,4-二氯苯-对硝基苯基醚)是一种除草剂,当在第9天或第10天给怀孕的啮齿动物喂食时,会造成胎儿膈疝和/或肺发育不全。当用硝芬处理时,胎儿表现出上皮细胞不成熟和发育不全。
英文摘要
DESCRIPTION (provided by applicant): Congenital diaphragmatic hernia (CDH) is associated with the structural abnormality of pulmonary hypoplasia. These changes are mimicked in the rodent model of nitrofen-induced CDH. Nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether) is an herbicide that when fed to a pregnant rodent at day 9 or 10 creates diaphragmatic hernia and/or lung hypoplasia in the fetuses. When treated with nitrofen the fetuses demonstrate epithelial cell immaturity as well as hypoplasia. In contrast, the investigators have found that in utero gene therapy with CFTR (the gene responsible for Cystic Fibrosis) results in epithelial cell hyperplasia and accelerated epithelial cell differentiation. The investigators hypothesize that in utero gene therapy with cftr will reduce the pulmonary hypoplasia and epithelial cell immaturity associated with CDH. This hypothesis can be tested in the fetal rat by treatment with nitrofen at 9-10 days gestation followed by in utero gene therapy at 16-17 days gestation.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Inspiratory muscle strength in COPD
Nurse managed upper body strength training in COPD
CORE--BIOBEHAVIORAL METHODS CORE
Lung Development in Congenital Diaphragmatic Hernia
  • 批准号:
    6679292
  • 项目类别:
  • 资助金额:
    $6.83万
  • 财政年份:
    2003
  • 负责人:
    JANET E LARSON
  • 依托单位:
海外基金